ArticleEuropean urology2019

Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect.

Filippo Pederzoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.